The Board of Directors has direct access to independent experts - lawyers, accountants and compensation experts - to turn to for counsel regarding specific company policies and activities.
The Audit Committee of the Board of Directors pre-approves all audit and permitted non-audit services, and reviews quarterly and year-end financial statements and associated press releases with our financial management and outside, independent auditors in advance of the filing or release of such documents.
The Compensation Committee of the Board of Directors approves all compensation-related matters involving Alphatec Spine's senior management. In addition, The Compensation Committee of the Board of Directors approves all bonus plans and acts as the administrator of the company's stock option plan and employee stock purchase plan.
Mortimer Berkowitz III was appointed to serve as Alphatec's Chairman of the Board of Directors in July 2007 and has served as a Director of Alphatec Holdings and Alphatec Spine since July 2005. He is currently a managing member of HGP, LLC, which is the general partner of HealthpointCapital, and President, a member of the Board of Managers and a managing director of HealthpointCapital, LLC. He has held the position with HGP, LLC since its formation in August 2002, the positions of managing director and member of the Board of Managers of HealthpointCapital, LLC since its formation in July 2002 and the position of President of HealthpointCapital, LLC since February 2005. Prior to joining HealthpointCapital, LLC, Mr. Berkowitz was managing director and co-founder of BPI Capital Partners, LLC, a private equity firm founded in 1990. Prior to 1990, Mr. Berkowitz spent 11 years in the investment banking industry with Goldman, Sachs & Co., Lehman Brothers Incorporated and Merrill Lynch & Co. He is a director of Scient'x S.A. and BioHorizons, Inc, both medical device companies, and on the Leadership Council of the Harvard School of Public Health. He received a Bachelor of Arts degree from Harvard College and an MBA from the Columbia Graduate School of Business.
John H. Foster
Director
John H. Foster is the former President, Chief Executive Officer and Chairman of the Board of Directors of Alphatec Spine. Mr. Foster is a 35 year veteran of private equity investing. As a successful entrepreneur and executive, Mr. Foster founded two private equity firms: Foster Management Company in 1972 and HealthpointCapital in 2002. From 1980 to 1997, he served as Chairman and CEO of Novacare, Inc. of Foster Medical Corporation. He is currently a Member of the Board of Directors of Scient'x S.A. and BioHorizons. Mr. Foster is on the Dean's Council at the Harvard School of Public Health, a Trustee of the Burke Rehabilitation Hospital, and formerly a Board Member of Avon, Inc. and Corning Incorporated. Mr. Foster received a B.A. from Williams College and an M.B.A. from Amos Tuck School at Dartmouth.
Siri S. Marshall
Director
Siri S. Marshall, Esq. has served as a Director of Alphatec Holdings and Alphatec Spine since October 2008. Ms. Marshall is the former Senior Vice President, General Counsel and Secretary and Chief Governance and Compliance Officer at General Mills, Inc., having retired from those positions in January 2008. In addition, Ms. Marshall managed General Mills' Tax function from 1994 to 1999 and its Corporate Affairs group from 1999 to 2005. Prior to joining General Mills in 1994, Ms. Marshall was Senior Vice President, General Counsel and Secretary of Avon Products, Inc. Ms. Marshall also is a director of Ameriprise Financial, Inc., Equifax, Inc. and the Yale Center for the Study of Corporate Law, a Distinguished Advisor to the Strauss Institute for Dispute Resolution, and a Trustee of the Minneapolis Institute of Arts. In the past she has served as a director of the American Arbitration Association and the Yale Law School Fund. She has also served as a member of The New York Stock Exchange Legal Advisory Committee. Ms. Marshall received her undergraduate from Harvard University and her Juris Doctrate from the Yale Law School.
R. Ian Molson
Director
R. Ian Molson has served as a Director of Alphatec Holdings and Alphatec Spine since July 2005. Mr. Molson has served as a Director of HealthpointCapital LLC since 2004, as a Director of Sapphire Industrials Corp. since 2007 and as a Director of Cayzer Continuation PCC, an investment company, since September 2002. From June 1999 to May 2004, Mr. Molson served as Deputy Chairman for the Board of Directors, Chairman of the Executive Committee and as a member of the Audit and Financial Committee and the Human Resources and Corporate Governance Committee of Molson, Inc., one of the world's largest brewers. Between 1977 and 1997, he was employed by Credit Suisse First Boston in various capacities, including Managing Director. From 1993 to 1997, Mr. Molson served as Head of the Investment Banking Department in Europe, a position which encompassed corporate finance, corporate advisory, mergers and acquisitions businesses in Europe, Russia, Africa and the Middle East. Mr. Molson received a Bachelor of Arts degree from Harvard University.
Stephen E. O'Neil has served as a Director of Alphatec Holdings and Alphatec Spine since July 2005. In May 1991, he founded The O'Neil Group, which provides legal and financial advice to clients primarily in the areas of mergers and acquisitions, financings and corporate strategy, where he has served as the principal since its inception. Prior to 1991, Mr. O'Neil formed a law partnership with Paul Mishkin under the name Mishkin, O'Neil for the purpose of engaging in general corporate and business law. Prior to that, he co-founded two corporations, Syntro Corporation and NovaCare, Inc., which have since become public companies. Mr. O'Neil received a Bachelor of Arts from Princeton University and a L.L.B. from Harvard Law School.
Dr. Stephen Hochschuler has served as a Director of Alphatec Holdings and Alphatec Spine since October 2006. Dr. Hochschuler has been the Chairman of the Company's Scientific Advisory Board since October 2005. Dr. Hochschuler is the Chairman and a Co-Founder of the Texas Back Institute and began serving as Chairman in 1980. Dr. Hochschuler has been an orthopedic surgeon specializing in spinal disorders since 1977 and his surgical practices are conducted in Plano, Texas and Phoenix, Arizona. Dr. Hochschuler is a founding member of the Board of Directors of the Spine Arthroplasty Society. He is an active member of the Texas Spine Society, the American Board of Spine Surgeons, the American Academy of Orthopedic Surgeons and the American Pain Society. Dr. Hochschuler received his M.D. from Harvard Medical School and his B.A. from Columbia College.
James R. Glynn
Director
James R. Glynn has served as a Director of Alphatec Holdings since May 2007. Mr. Glynn spent much of his career in leadership positions at Invitrogen, a publicly held biotechnology company (Nasdaq:IVGN). From December 2002 to July 2003, Mr. Glynn served as the Chief Executive Officer, President and Chief Operating Officer, and from May 1998 to December 2002, he was the Executive Vice President and Chief Financial Officer of Invitrogen. Prior to Invitrogen, Mr. Glynn served as Chief Operating Officer, Chief Financial Officer and a member of the board of directors of Matrix Pharmaceutical, Inc., a pharmaceutical company focused on the treatment of cancer. Mr. Glynn is currently a Director and Chairman of the Audit Committee at American Specialty Health and a Director of eBioscience, Inc. Mr. Glynn holds a B.B.A. degree in accounting from Cleveland State University.
Rohit M. Desai has served as a Director of Alphatec Holdings and Alphatec Spine since February 2008. Mr. Desai is Chairman, President and Chief Investment Officer of Desai Capital Management Incorporated (DCMI) which he founded in 1984. DCMI is a New York-based private equity investment firm that acquired or provided equity capital to growth companies. Since inception, it has sponsored four institutional investment partnerships, each with committed capital between $325 million and $410 million. All of these partnerships have now successfully completed their investment programs and proceeds from the sales of investments have been distributed to the limited partners. Prior to forming Desai Capital Management in 1984, Mr. Desai spent 20 years with Morgan Guaranty Trust, an affiliate of J.P. Morgan where he was a Senior Vice President, Head of Special Investments, which included private equity, real estate, venture capital and oil and gas investments, and a member of the Trust and Investment Committee at the time he left that organization to start his own firm. Mr. Desai is also a director of The Independence Community Foundation, Finlay Enterprises, Inc., Atlas Acquisition Holdings Corp., and Motif, Inc. Mr. Desai earned a Bachelor of Science from the University of Bombay, a Master of Science from the University of North Carolina and a Master of Business Administration from Harvard Business School.
Dirk Kuyper
Director, President and Chief Executive Officer
Dirk Kuyper has served as a Director of Alphatec Holdings and Alphtec Spine since February 2008. Dirk Kuyper joined Alphatec Spine as President and Chief Executive Officer in June of 2007. Mr. Kuyper came to Alphatec Spine from a successful career at Aesculap, Inc. From 2004 to 2007, he served as the President; from 2001 to 2004, he served as the Executive Vice President and Chief Operating Officer; from 1998 to 2001, he served as the Executive Vice President of Sales and Marketing at Aesculap; and from 1990 to 1998 he held various sales positions of increasing responsibility. Mr. Kuyper served on active duty for four years in the U.S. Army where he achieved the rank of Captain. Mr. Kuyper holds a B.S. in Biology from the University of Miami and an Executive Education Certificate from the Graduate School of Sales and Marketing at Syracuse University
show all
hide all
